Mary Clare Kennedy1,2,3, Thomas H Kerr1,2,4, Evan Wood1,2,4, Jeannie A Shoveller2,3, Julio S G Montaner2,4, M-J S Milloy1,2,4. 1. British Columbia Centre on Substance Use. 2. British Columbia Centre for Excellence in HIV/AIDS, St. Paul's Hospital. 3. School of Population and Public Health. 4. Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Abstract
OBJECTIVES: Although previous cross-sectional studies have identified correlates of detectable plasma HIV-1 RNA viral load (VL) among HIV-positive people who use drugs (PWUD), longitudinal factors associated with heightened HIV transmission potential have not been well described. Therefore, we longitudinally examined factors associated with amount of person-time spent above log10(1500) copies/ml plasma among HIV-positive PWUD in Vancouver, Canada. DESIGN: Data were derived from a long-running prospective cohort of HIV-positive PWUD linked to comprehensive clinical records including systematic VL monitoring. METHODS: We used generalized estimating equations modeling to longitudinally examine factors associated with person-time (in days) with a VL more than log10(1500) copies/ml plasma in the previous 180 days. RESULTS: Between December 2005 and May 2014, 845 PWUD were eligible and included in the study. Participants spent an average of 26.8% of observation time with a VL more than log10(1500) copies/ml. In multivariable analyses, homelessness (Adjusted Rate Ratio [ARR] = 1.45) and lack of social support (ARR = 1.27) were positively associated with person-time with a VL more than log10(1500) copies/ml. Older age (ARR = 0.97) and enrolment in addiction treatment (ARR = 0.75) were negatively associated with the outcome in multivariable analyses (all P < 0.05). CONCLUSION: Social and structural factors, including periods of homelessness or lacking in social support, were independently associated with greater amount of time with heightened HIV transmission potential. These findings suggest the need for targeted efforts to address modifiable contextual factors that contribute to increased risk of onward HIV transmission among PWUD.
OBJECTIVES: Although previous cross-sectional studies have identified correlates of detectable plasma HIV-1 RNA viral load (VL) among HIV-positive people who use drugs (PWUD), longitudinal factors associated with heightened HIV transmission potential have not been well described. Therefore, we longitudinally examined factors associated with amount of person-time spent above log10(1500) copies/ml plasma among HIV-positive PWUD in Vancouver, Canada. DESIGN: Data were derived from a long-running prospective cohort of HIV-positive PWUD linked to comprehensive clinical records including systematic VL monitoring. METHODS: We used generalized estimating equations modeling to longitudinally examine factors associated with person-time (in days) with a VL more than log10(1500) copies/ml plasma in the previous 180 days. RESULTS: Between December 2005 and May 2014, 845 PWUD were eligible and included in the study. Participants spent an average of 26.8% of observation time with a VL more than log10(1500) copies/ml. In multivariable analyses, homelessness (Adjusted Rate Ratio [ARR] = 1.45) and lack of social support (ARR = 1.27) were positively associated with person-time with a VL more than log10(1500) copies/ml. Older age (ARR = 0.97) and enrolment in addiction treatment (ARR = 0.75) were negatively associated with the outcome in multivariable analyses (all P < 0.05). CONCLUSION: Social and structural factors, including periods of homelessness or lacking in social support, were independently associated with greater amount of time with heightened HIV transmission potential. These findings suggest the need for targeted efforts to address modifiable contextual factors that contribute to increased risk of onward HIV transmission among PWUD.
Authors: Evan Wood; Robert S Hogg; Benita Yip; P Richard Harrigan; Julio S G Montaner Journal: J Acquir Immune Defic Syndr Date: 2005-03-01 Impact factor: 3.731
Authors: Amy R Knowlton; Julia H Arnsten; Lois J Eldred; James D Wilkinson; Starley B Shade; Amy S Bohnert; Cui Yang; Lawrence S Wissow; David W Purcell Journal: AIDS Patient Care STDS Date: 2010-07 Impact factor: 5.078
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: M-J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Andrea Krusi; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood Journal: J Acquir Immune Defic Syndr Date: 2012-04-01 Impact factor: 3.731
Authors: Gregory K Robbins; Kristin L Johnson; Yuchiao Chang; Katherine E Jackson; Paul E Sax; James B Meigs; Kenneth A Freedberg Journal: Clin Infect Dis Date: 2010-03-01 Impact factor: 9.079
Authors: Carl A Latkin; M Kumi Smith; Tran Viet Ha; Tran Thi Mo; Carla Zelaya; Teerada Sripaipan; Nguyen Le Minh; Vu Minh Quan; Vivian F Go Journal: AIDS Behav Date: 2016-11
Authors: M-J Milloy; Evan Wood; Thomas Kerr; Bob Hogg; Silvia Guillemi; P Richard Harrigan; Julio Montaner Journal: Clin Infect Dis Date: 2015-11-08 Impact factor: 9.079
Authors: Becky L Genberg; Gregory D Kirk; Jacquie Astemborski; Hana Lee; Noya Galai; Kenrad E Nelson; David Vlahov; David D Celentano; Shruti H Mehta Journal: Am J Epidemiol Date: 2019-12-31 Impact factor: 5.363
Authors: Martin Plymoth; Eduard J Sanders; Elise M Van Der Elst; Patrik Medstrand; Fregenet Tesfaye; Niclas Winqvist; Taye Balcha; Per Björkman Journal: PLoS One Date: 2020-12-15 Impact factor: 3.240